Warning letter
Sportron International, Inc.: warning letter of Aug 23, 2019
FDA warning letter 579475 · Office of Human and Animal Food West Division 3
Key facts
| Reference number | 579475 |
|---|---|
| Company | Sportron International, Inc. |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Aug 23, 2019 |
| Posted date | Sep 3, 2019 |
| Issuing office | Office of Human and Animal Food West Division 3 |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.73, 111.75, 111.103, 111.70(b)(1), 111.70(b)(2), 111.70(f), 111.70(g), 111.95(b)(1), 111.127(h), 111.140(b)(2), 111.140(b)(3) and 2 more |
| Inspection city | Whitewright |
| Inspection ZIP | 75491 |
| Inspection start date | Mar 22, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: